title: The effect of the thromboxane receptor antagonist GR32191B on cyclosporine-induced nephrotoxicity.
authors.affiliation: Department of Surgery, Leicester General Hospital, UK.
authors.forename: G E
authors.initials: GE
authors.lastname: Mobb
authors.forename: P H
authors.initials: PH
authors.lastname: Whiting
authors.forename: J
authors.initials: J
authors.lastname: Feehally
authors.forename: P S
authors.initials: PS
authors.lastname: Veitch
authors.forename: P R
authors.initials: PR
authors.lastname: Bell
mesh_terms: D001713:Biphenyl Compounds / Q000627:therapeutic use*; D003524:Cyclosporins / Q000009:adverse effects*; D004311:Double-Blind Method; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000379:methods*; D011453:Prostaglandins / Q000097:blood; D011982:Receptors, Prostaglandin / Q000187:drug effects*; D017482:Receptors, Thromboxane
chemical_list: D001713:Biphenyl Compounds; D003524:Cyclosporins; D006538:Heptanoic Acids; D011453:Prostaglandins; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; C060013:vapiprost